Mazdutide is a synthetic peptide and dual agonist of the GLP-1 and glucagon receptors, developed within the broader category of multi-pathway incretin research compounds. It has been studied in metabolic research for its relationship to glucose handling, energy expenditure, adiposity, and hepatic metabolic signaling across controlled preclinical and clinical models. Its balanced GLP-1 and glucagon receptor activity distinguishes it from earlier incretin-only designs and places it within a newer generation of dual-pathway metabolic peptides. Lyophilized powder, 3mL vial. Sold at 10mg per vial. For research use only.
